Drug makers can't make knockoff weight-loss drugs
Drug makers can’t make knockoff weight-loss drugs anymore—and they’re mad
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to the drug makers, writing in bold that the agency "reminds compounders of the legal restrictions on making copies of FDA-approved drugs."
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.
On January 20, 2026, the Food and Drug Administration's (FDA) new traceability rules — dubbed the Food Traceability Final ...
Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...
▪ Freeze bags of water. When frozen, they can be shoved into spaces between food packages to help keep the freezer cold. As ...
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in ...
Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...
Careers in food science not only focus on improving food quality but also on addressing challenges like food security, waste ...
Issue: Whether a manufacturer may file a petition for review in a circuit (other than the U.S. Court of Appeals for the District of Columbia Circuit) where it neither resides nor has its principal ...
The Food and Drug Administration has granted authorization of a COVID-19 and flu test that can be used without a prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback